John B. Payne - Jun 5, 2024 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Signature
/s/ John B. Payne
Stock symbol
ZIVO
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/6/2024, 06:25 PM
Previous filing
Apr 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Disposed to Issuer -1.9K -100% 0 Jun 5, 2024 Common Stock 1.9K $26.88 Direct F1, F2, F3
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Disposed to Issuer -32K -100% 0 Jun 5, 2024 Common Stock 32K $33.00 Direct F1, F2, F3
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Disposed to Issuer -31.8K -100% 0 Jun 5, 2024 Common Stock 31.8K $17.16 Direct F1, F2, F3
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award +167K 167K Jun 5, 2024 Common Stock 167K $7.96 Direct F3, F4
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +50.3K $0.00 50.3K Jun 5, 2024 Common Stock 50.3K $7.96 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023.
F2 The canceled options were fully vested.
F3 The Issuer canceled options for an aggregate 65,738 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, and 12/16/2022. In exchange for the canceled options, the Reporting Person received a replacement option, for 167,180 shares, having an exercise price of $7.96.
F4 The option was issued pursuant to the 2021 Equity Incentive Plan and all options vested immediately upon the date of acceptance of grant.